Skip to main content
SupplementScience

Shatavari Research & Evidence

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Emerging

Shatavari has been extensively studied in Ayurvedic pharmacological research, though large-scale Western-style RCTs are limited. Alok et al. (2013) published a comprehensive review of its pharmacological properties, documenting estrogenic, galactagogue, anti-ulcer, and immunomodulatory effects. The lactation evidence, while promising, comes from small clinical studies. Gautam et al. (2009) provided strong preclinical evidence for immunomodulatory effects. The main limitation is that most evidence comes from traditional use, animal studies, and small human trials — larger RCTs are needed to confirm efficacy for its primary indications.

Evidence by Condition

ConditionStudied DoseEvidence
Lactation support500mg extract twice dailyEmerging
Menstrual/hormonal support500-1000mg extract twice dailyEmerging
Menopausal symptoms500-1000mg extract twice dailyPreliminary
Digestive support500mg extract twice dailyEmerging

References

  1. (). Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review. Asian Pacific Journal of Tropical Disease. DOI
  2. (). Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity. Journal of Ethnopharmacology. DOI